Cooperative inhibitory effect of novel mixed backbone oligonucleotide targeting protein kinase A in combination with docetaxel and anti-epidermal growth factor-receptor antibody on human breast cancer cell growth

Clinical Cancer Research

Volumn 5, Issue 4, 1999, Pages 875-881

  Tortora, Giampaolo ^a   Caputo, Rosa ^a   Pomatico, Grazia ^a   Pepe, Stefano ^a   Bianco, A Raffaele ^a   Agrawal, Sudhir ^b   Mendelsohn, John ^c   Ciardiello, Fortunato ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b HYBRIDON INC   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CETUXIMAB; CYCLIC AMP DEPENDENT PROTEIN KINASE; DOCETAXEL; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; MONOCLONAL ANTIBODY; OLIGONUCLEOTIDE; RECEPTOR ANTIBODY; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CONTROLLED STUDY; GENE TARGETING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL DIVISION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; FEMALE; FLOW CYTOMETRY; HUMANS; OLIGONUCLEOTIDES, ANTISENSE; OLIGORIBONUCLEOTIDES, ANTISENSE; PACLITAXEL; RECEPTOR, EPIDERMAL GROWTH FACTOR; TAXOIDS; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 0032951396     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Cho-Chung, Y. S., and Clair, T. The regulatory subunit of cAMP-dependent protein kinase as a target for chemotherapy of cancer and other cellular dysfunctional-related diseases. Pharmacol. Ther., 60: 265-288, 1993.
2. Tortora, G., Pepe, S., Bianco, C., Baldassarre, G., Budillon, A., Clair, T., Cho-Chung, Y. S., Bianco, A. R., and Ciardiello, F. The RIα subunit of protein kinase A controls serum dependency and entry into cell cycle of human mammary epithelial cells. Oncogene, 9: 3233-3240, 1994.
3. Tortora, G., Ciardiello, F., Ally, S., Clair, T., Salomon, D. S., and Cho-Chung, Y. S. Site-selective 8-chloro-adenosine 3′,5′ monophosphate inhibits transformation and transforming growth factor α production in Ki-ras-transformed rat fibroblasts. FEBS Lett., 242: 363-367, 1989.
4. Ciardiello, F., Tortora, G., Kim, N., Clair, T., Ally, S., Salomon, D. S., and Cho-Chung, Y. S. 8-Cl-cAMP inhibits transforming growth factor α transformation of mammary epithelial cells by restoration of the normal mRNA patterns for cAMP-dependent protein kinase regulatory subunit isoforms which show disruption upon transformation. J. Biol. Chem., 265: 1016-1020, 1990.
5. Tortora, G., Damiano, V., Bianco, C., Baldassarre, G., Bianco, A. R., Lanfrancone, L., Pelicci, P. G., and Ciardiello F. The RIα subunit of protein kinase A (PKA) binds to Grb2 and allows PKA interaction with the activated EGF-receptor. Oncogene, 14: 923-928, 1997.
6. Miller, W. R., Watson, D. M. A., Jack, W., Chetty, U., and Elton, R. A. Tumor cyclic AMP binding proteins: an independent prognostic factor for disease recurrence and survival in breast cancer. Breast Cancer Res. Treat., 26: 89-94, 1993.
7. Simpson, J. B. B., Ramage, A. D., Hulme, M. J., Burns, D. J., Katsaros, D., Langdon, S., and Miller W. R. Cyclic adenosine 3′,5′-monophosphate-binding proteins in human ovarian cancer: correlations with clinicopathological features. Clin. Cancer Res., 2: 201-206, 1996.
8. Tortora, G., Clair, T., and Cho-Chung, Y. S. An antisense oligodeoxynucleotide targeted against the type IIβ regulatory subunit mRNA of protein kinase inhibits cAMP-induced differentiation in HL-60 leukemia cells without affecting phorbol ester effects. Proc. Natl. Acad. Sci. USA, 87: 705-708, 1990.
9. Tortora, G., Yokozaki, H., Pepe, S., Clair, T., and Cho-Chung, Y. S. Differentiation of HL-60 leukemia by type I regulatory subunit antisense oligodeoxynucleotide of cAMP-dependent protein kinase. Proc. Natl. Acad. Sci. USA, 88: 2011-2015, 1991.
10. Yokozaki, H., Budillon, A., Tortora, G., Meissner, S., Beaucage, S. L., Miki, K., and Cho-Chung, Y. S. An antisense oligodeoxynucleotide that depletes RIα subunit of cyclic AMP-dependent protein kinase induces growth inhibition in human cancer cells. Cancer Res., 53: 868-872, 1993.
11. Ciardiello, F., Pepe, S., Bianco, C., Baldassarre, G., Ruggiero, A., Bianco, C., Selvam, M. P., Bianco, A. R., and Tortora, G. Downregulation of RIα subunit of the cAMP-dependent protein kinase induces growth inhibition of human mammary epithelial cells transformed by c-Ha-ras and c-erbB-2 protooncogenes. Int. J. Cancer, 53: 438-443, 1993.
12. Nesterova, M., and Cho-Chung, Y. S. A single-injection protein kinase A-directed antisense treatment to inhibit tumor growth. Nat. Med., 1: 528-533, 1995.
13. Akhtar, S., and Agrawal, S. In vivo studies with antisense oligonucleotides. Trends Pharmacol. Sci., 18: 12-18, 1997.
14. Agrawal, S., Jiang, Z., Zhao, Q., Shaw, D., Cai, Q., Roskey, A., Channavajiala, L., Saxinger, C., and Zhang, R. Mixed backbone oligonucleotides as second generation antisense oligonucleotides: in vitro and in vivo studies. Proc. Natl. Acad. Sci. USA, 94: 2620-2625, 1997.
15. Tortora, G., Caputo, R., Damiano, V., Bianco, R., Pepe, S., Bianco, A. R., Jiang, Z., Agrawal, S., and Ciardiello, F. Synergistic inhibition of human cancer cell growth by cytotoxic drugs and mixed backbone antisense oligonucleotide targeting protein kinase A. Proc. Natl. Acad. Sci. USA, 94: 12586-12591, 1997.
16. Salomon, D. S., Brandt, R., Ciardiello, F., and Normanno, N. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit. Rev. Oncol. Hematol., 19: 183-232, 1995.
17. Dixon, R. B., and Lippman, M. E. Molecular biology of breast cancer. In: V. T. De Vita, S. Hellman, and S. A. Rosemberg (eds.), Cancer: Principles and Practice of Oncology, pp. 1541-1551. Philadelphia: J. B. Lippincott-Raven, 1997.
18. Fox, S. B., and Harris, A. L. The epidermal growth factor receptor in breast cancer. J. Mamm. Gland Biol. Neoplasia, 2: 131-141, 1997.
19. Ciardiello, F., and Tortora, G. Interactions between the epidermal growth factor receptor and type I protein kinase A: biological significance and therapeutic implications. Clin. Cancer Res., 4: 821-828, 1998.
20. Goldstein, N. I., Prewett, M., Zuklys K., Rockwell, P., and Mendelsohn, J. Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model. Clin. Cancer Res., 1: 1311-1318, 1995.
21. Ciardiello, F., Damiano, V., Bianco, R., Bianco, C., Fontanini, G., De Laurentiis, M., De Placido, S., Mendelsohn, J., Bianco, A. R., and Tortora, G. Antitumor activity of combined blockade of epidermal growth factor receptor and protein kinase A. J. Natl. Cancer Inst., 88: 1770-1776, 1996.
22. Ciardiello, F., Caputo, R., Bianco, R., Damiano, V., Pomatico, G., Pepe, S., Bianco, A. R., Agrawal, S., Mendelsohn, J., and Tortora, G. Cooperative inhibition of renal cancer growth by an anti-epidermal growth factor receptor antibody and protein kinase A antisense oligonucleotide. J. Natl. Cancer Inst., in press, 1999.
23. Blagosklonny, M. V., Giannakakou, P., El-Deiry, W. S., Kingston, D. G., Higgs, P. I., Neckers, L, and Fojo, T. Raf-1/bcl-2 phosphorylation: a step from microtubule damage to cell death. Cancer Res., 57: 130-135, 1997.
24. Srivastava, R. K., Srivastava, A. R., Korsmeyer, S. J., Nesterova, M., Cho-Chung, Y. S., and Longo, D., L. Involvement of microtubules in the regulation of Bcl2 phosphorylation and apoptosis through cyclic AMP-dependent protein kinase. Mol. Cell. Biol., 18: 3509-3517, 1998.
25. Zhang, R., Cai, Q., Li, Y., Xu, J., Xie, X., Tan, W., and Agrawal, S. Novel mixed backbone oligonucleotides (MBO) targeted at protein kinase A with improved in vivo antitumor activities against human cancer xenografts. Proc. Am. Assoc. Cancer Res., 38: 316, 1997.
26. Chan, S., Friedrichs, K., Noel, D., Duarte, R., Vorobiof, D., Pinter, T., Yelle, L., Alaki, M., Murawsky, M., and Riva, A. A randomized phase II study of Taxotere versus doxorubicin in patients with metastatic breast cancer who have failed an alkylating containing regimen: preliminary results. Proc. Am. Soc. Clin. Oncol., 16: 540, 1997.
27. Nicoletti, I., Migliorati, G., Pagliacci, M. C., Grignani, F., and Riccardi, C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods, 139: 271-279, 1991.
28. Beebe, S. J., Holloway, R., Rannels, S. R., and Corbin, J. D. Two classes of cAMP analogs which are selective for the two different cAMP binding sites of type II protein kinase demonstrate synergism when added together to intact adipocytes. J. Biol. Chem., 259: 3539-3547, 1984.
29. Baselga, J., and Mendelsohn, J. Type I receptor tyrosine kinases as targets for therapy in breast cancer. J. Mamm. Gland Biol. Neoplasia., 2: 165-174, 1997.
30. Fan, Z., Baselga, J., Masui, H., and Mendelsohn, J. Antitumor effect of anti-epidermal growth factor receptor monoclonal antibodies plus cis-diamminedichloroplatinum on well established A431 cell xenografts. Cancer Res., 53: 4637-4642, 1992.
31. Slavin, S. F., Kelly, W. K., Cohen, R., Cooper, M., Malone, T., Weingard, K., Waksal, H., Falcey, J., Mendelsohn, J., and Scher, H. I. Epidermal growth factor receptor monoclonal antibody C225 and doxorubicin in androgen-independent prostate cancer: results of a phase Ib/IIa study. Proc. Am. Soc. Clin. Oncol., 16: 1108, 1997.
32. Wu, X., Fan, Z., Masui, H., Rosen, N., and Mendelsohn, J. Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin. J. Clin. Invest., 95: 1897-1905, 1995.
33. Mendelsohn, J., and Fan, Z. Epidermal growth factor receptor family and chemosensitization. J. Natl. Cancer Inst., 89: 341-343, 1997.
34. Skorsky, T. M., Nieborowska-Skorska, M., Wlodarski, P., Perrotti, D., Hoser, G., Kawiak, J., Majewski, M., Christensen, L., Iozzo, R. V., and Calabretta, B. Treatment of Philadelphia leukemia in severe combined immunodeficient mice by combination of cyclophosphamide and bcr/abl antisense oligodeoxynucleotides. J. Natl. Cancer Inst., 89: 124-133, 1997.
35. Geiger, T., Muller, M., Monia, B. P., and Fabbro, D. Antitumor activity of a c-raf antisense oligonucleotide in combination with standard chemotherapeutic agents against various human tumors transplanted subcutaneously into nude mice. Clin. Cancer Res., 3: 1179-1185, 1997.
36. Citro, G., D'Agnano, I., Leonetti, C., Perini, R., Bucci, B., Zon, G., Calabretta, B., and Zupi, G. c-myc antisense oligodeoxynucleotides enhance the efficacy of cisplatin in melanoma chemotherapy in vitro and in nude mice. Cancer Res., 58: 283-289, 1998.